Insights

  • Date

  • Content Type

  • Reset

Blog

Simultaneous National Scientific Advice

4.05.20

By Maria Schacker

Until recently, scientific advice from national authorities had to be obtained from each authority individually. A new pilot...

Read More

Blog

A guide to scientific due diligence: How to set up an efficient process Part 2

30.04.20

By Dr. Diane Seimetz

Diane Seimetz was invited as lecturer to the top notch Pharma MBA to speak about how to successfully...

Read More

Blog

What you should know about potency assays

22.04.20

By Linsey Reavie

A validated potency assay is an essential component for the specifications of a biopharmaceutical. We have summarized the...

Read More

Blog

Postponement of the medical device regulation (MDR) – chances and challenges

12.04.20

By Franz-Josef Binmöller

The European Parliament has postponed the implementation of the medical device regulation by one year. Medical device developers,...

Read More

Blog

Accelerated development and licensure of Coronavirus vaccines

28.02.20

By Michael Pfleiderer

The newly emerging 2019 novel Coronavirus is threatening the world as it spreads with a so far unprecedented...

Read More

Blog

Recombinant viruses driving game-changing therapies

18.02.20

By Jörg Schneider

Recent years saw the approval of several Advanced Therapy Medicinal Products (ATMPs) using recombinant viruses and the pipeline...

Read More

We are now Cencora PharmaLex 

PharmaLex is now part of Cencora, a leading global healthcare company with a foundation in pharmaceutical distribution. In 2024 and beyond PharmaLex and all the companies in PharmaLex family will begin a journey to becoming Cencora as well. Cencora brings the companies and services together under one new name. The name will change, but the level of attention and service you receive remains the same.  

Know more